While the significant tendency of reduced APP (130 kDa) as seen by Western blot in human patients with AD was supported by findings in our 3xTg group (110 kDa), the secretion of APPβ in transgenic animals is reversely pronounced as compared to humans. This evidence concerns the gene APP and Alzheimer disease.